Assignee
DELIVRA INC
CA·2 granted patents·4 pending applications·0 citations·filing 2016–2018
Top patents by PatentIndex Score
6 records- 0134US11896575B2Transdermal formulation for delivery of hydrophobic compounds and process for the preparation thereofDELIVRA INC·Filed 2018·Granted Feb 13, 2024·0 cites·20 claims
- 0230US2019142738A1Transdermal formulations for delivery of celecoxib and its use in the treatment of celecoxib-responsive diseases and conditionsDELIVRA INC·Filed 2017·Application pending·0 cites
- 0328US2018243212A1Transdermal formulations for delivery of doxycycline, and their use in the treatment of doxycycline-responsive diseases and conditionsDELIVRA INC·Filed 2016·Application pending·0 cites
- 0428US2019046481A1Transdermal formulations for delivery of propionic and acetic acid nsaids, and their use in the treatment of nsaid-responsive diseases and conditionsDELIVRA INC·Filed 2016·Application pending·0 cites
- 0526US10898537B2Transdermal formulations for delivery of capsaicinoidsDELIVRA INC·Filed 2016·Granted Jan 26, 2021·0 cites·19 claims
- 0623US2018235870A1Transdermal formulations for delivery of berberine compounds, and their use in the treatment of berberine-responsive diseases and conditionsDELIVRA INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DELIVRA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →